Dylan S.

Dylan S. currently serves as Vice President of US Medical Affairs at Alnylam Pharmaceuticals since September 2023. Prior experience includes leadership roles at Biogen, where Dylan was Head of Neuropsychiatry, and Philips, where responsibilities encompassed both Regulatory Affairs and Global Medical Affairs within the Connected Care Cluster. Dylan has held significant positions at BD, GSK, Boehringer Ingelheim, and Sanofi, focusing on medical strategy, clinical development, and market access across various therapeutic areas, particularly in diabetes and psychiatry. Educational credentials include an MBA from MIT Sloan School of Management, a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences, and extensive post-doctoral training in medical affairs and clinical pharmacy.